About Allakos (ALLK)
Allakos Inc. is a clinical stage biopharmaceutical company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory and proliferative disea... Read more
- USD1.15
- USD1.17
- USD1.11
- USD5.64
- -9.40%
- --
- 182.04k
- 385.63k
- 90M
- 0.98
- -73.00%
Stock News
2 hours ago
Meet the Newest Artificial Intelligence (AI) Stock in the S&P 500. It Soared 1,700% in 2 Years, and Wall Street Says the Stock Is Still a Buy
Yahoo
2 hours ago
Q1 2024 Newpark Resources Inc Earnings Call
Yahoo
2 hours ago
Most Investors Think They're Boring Companies. But These 2 Businesses Are Unstoppable and Are Reaching New Highs in 2024.
Yahoo
3 hours ago
2 Energy Stocks That Are Screaming Buys in May
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
